High Resolution Image Download MS PowerPoint Slide Mo V −Mo VI mixed valence polyoxometalates (POMs), H 7 [β-P(Mo V ) 4 (Mo VI ) 8 O 40 ] ( 1 ), (NH 4 ) 10 [(Mo V ) 4 (Mo VI ) 2 O 14 (O 3 PCH 2 PO 3 ) 2 (H 2 OPCH 2 PO 3 ) 2 ]·15H 2 O ( 2 ), and [ε-P(Mo V ) 8 (Mo VI ) 4 O 36 (OH) 4 {La(H 2 O) 2.5 Cl 1.25 } 4 ]·27H 2 O ( 3 ), respectively, were selected because they possess built-in reducing abilities. They were used for the synthesis of Pt 0 and Pd 0 nanoparticles (NPs) in water at room temperature without UV irradiation. Small size NPs (1.7−4 nm) were obtained, their stabilization following the order 1 > 2 ≫ 3 . They were characterized by transmission electron microscopy (TEM), X-ray photoelectron spectroscopy (XPS), and electrochemistry. Detection of molybdenum in XPS and electrochemistry supports the hypothesis that each polyoxometalate serves both as a reductant and as a protective layer, in agreement with the propensity, particularly of Mo-based POMs, to self-assemble on metal and other solid surfaces. The Pt 0 and Pd 0 NPs were tested for the electrocatalytic oxidation of methanol and ethanol, respectively, and proved efficient for these processes. In addition, Pt 0 was resistant to poisoning during methanol oxidation. The synthesis of these stabilized nanoparticles is facile and provides materials that show promise for use in fuel cells.
No takes yet. Share an insight, caveat, or question.
Keita et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: